Shehu-Xhilaga M, Crowe S M, Mak J
AIDS Pathogenesis Research Unit, Macfarlane Burnet Centre for Medical Research, Fairfield, Victoria, Australia.
J Virol. 2001 Feb;75(4):1834-41. doi: 10.1128/JVI.75.4.1834-1841.2001.
Production of the human immunodeficiency virus type 1 (HIV-1) Gag-Pol precursor protein results from a -1 ribosomal frameshifting event. In infected cells, this generates Gag and Gag-Pol in a ratio that is estimated to be 20:1, a ratio that is conserved among retroviruses. To examine the impact of this ratio on HIV-1 replication and viral assembly, we altered the Gag/Gag-Pol ratio in virus-producing cells by cotransfecting HIV-1 proviral DNA with an HIV-1 Gag-Pol expression vector. Two versions of the Gag-Pol expression vector were used; one contains an active protease [PR(+)], and the other contains an inactive protease [PR(-)]. In an attempt to produce viral particles with Gag/Gag-Pol ratios ranging from 20:21 to 20:1 (wild type), 293T cells were cotransfected with various ratios of wild-type proviral DNA and proviral DNA from either Gag-Pol expression vector. Viral particles derived from cells with altered Gag/Gag-Pol ratios via overexpression of PR(-) Gag-Pol showed a ratio-dependent defect in their virion protein profiles. However, the defects in virion infectivity were independent of the nature of the Gag-Pol expression vector, i.e., PR(+) or PR(-). Based on equivalent input of reverse transcriptase activity, we estimated that HIV-1 infectivity was reduced 250- to 1,000-fold when the Gag/Gag-Pol ratio in the virion-producing cells was altered from 20:1 to 20:21. Although virion RNA packaging was not affected by altering Gag/Gag-Pol ratios, changing the ratio from 20:1 to 20:21 progressively reduced virion RNA dimer stability. The impact of the Gag/Gag-Pol ratio on virion RNA dimerization was amplified when the Gag-Pol PR(-) expression vector was expressed in virion-producing cells. Virions produced from cells expressing Gag and Gag-Pol PR(-) in a 20:21 ratio contained mainly monomeric RNA. Our observations provide the first direct evidence that, in addition to proteolytic processing, the ratio of Gag/Gag-Pol proteins is also important for RNA dimerization and that stable RNA dimers are not required for encapsidation of genomic RNA in HIV-1.
人类免疫缺陷病毒1型(HIV-1)Gag-Pol前体蛋白的产生源于-1核糖体移码事件。在受感染细胞中,这会产生Gag和Gag-Pol,其比例估计为20:1,这一比例在逆转录病毒中是保守的。为了研究该比例对HIV-1复制和病毒组装的影响,我们通过将HIV-1前病毒DNA与HIV-1 Gag-Pol表达载体共转染,改变了病毒产生细胞中的Gag/Gag-Pol比例。使用了两种版本的Gag-Pol表达载体;一种含有活性蛋白酶[PR(+)],另一种含有无活性蛋白酶[PR(-)]。为了产生Gag/Gag-Pol比例范围从20:21到20:1(野生型)的病毒颗粒,将293T细胞与不同比例的野生型前病毒DNA以及来自任一Gag-Pol表达载体的前病毒DNA共转染。通过PR(-) Gag-Pol过表达使Gag/Gag-Pol比例改变的细胞所产生的病毒颗粒,其病毒体蛋白谱显示出比例依赖性缺陷。然而,病毒体感染性的缺陷与Gag-Pol表达载体的性质无关,即PR(+)或PR(-)。基于逆转录酶活性的等效输入,我们估计当病毒产生细胞中的Gag/Gag-Pol比例从20:1改变为20:21时,HIV-1感染性降低了250至1000倍。尽管改变Gag/Gag-Pol比例不会影响病毒体RNA包装,但将比例从20:1改变为20:21会逐渐降低病毒体RNA二聚体的稳定性。当在病毒产生细胞中表达Gag-Pol PR(-)表达载体时,Gag/Gag-Pol比例对病毒体RNA二聚化的影响会放大。以20:21比例表达Gag和Gag-Pol PR(-)的细胞所产生的病毒体主要含有单体RNA。我们的观察提供了首个直接证据,表明除蛋白水解加工外,Gag/Gag-Pol蛋白的比例对RNA二聚化也很重要,并且稳定的RNA二聚体对于HIV-1基因组RNA的包装不是必需的。